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Background. Streptococcus suis has emerged as an important cause of bacterial meningitis in adults. The inges-
tion of undercooked pork is a risk factor for human S. suis serotype 2 (SS2) infection. Here we provide experimental
evidence indicating that the gastrointestinal tract is an entry site of SS2 infection.
Methods. We developed a noninvasive in vivo model to study oral SS2 infection in piglets. We compared in vitro
interaction of S. suis with human and porcine intestinal epithelial cells (IEC).
Results. Two out of 15 piglets showed clinical symptoms compatible with S. suis infection 24–48 hours after in-
gestion of SS2. SS2 was detected in mesenteric lymph nodes of 40% of challenged piglets. SS2 strains isolated from
patients showed signiﬁcantly higher adhesion to human IEC compared to invasive strains isolated from pigs. In con-
trast, invasive SS9 strains showed signiﬁcantly higher adhesion to porcine IEC. Translocation across human IEC, which
occurred predominately via a paracellular route, was signiﬁcantly associated with clonal complex 1, the predominant
zoonotic genotype. Adhesion and translocation were dependent on capsular polysaccharide production.
Conclusions. SS2 should be considered a food-borne pathogen. S. suis interaction with human and pig IEC cor-
relates with S. suis serotype and genotype, which can explain the zoonotic potential of SS2.
Keywords. Streptococcus suis; intestinal translocation; zoonotic infections; serotype; clonal complex; tight junc-
tions; piglets.
Streptococcus suis is an emerging zoonotic pathogen,
which causes meningitis and septicaemia in humans
and pigs [1, 2]. Ingestion of S. suis serotype 2 (SS2)
contaminated food was identiﬁed as a risk factor for
meningitis caused by SS2 in adult patients in Vietnam
and Thailand [2], indicating that the gastrointestinal
tract (GIT) might serve as an entry site of SS2 infection
in humans [3, 4].
The upper respiratory tract (URT) is considered the
main entry site of S. suis infection in pigs [5]. However,
recent studies showed that the porcine GIT is rapidly
colonized by S. suis after weaning [6] and that bacterial
entry through the GIT occurs in piglets after mild stress
induction [7], indicating that also the porcine GIT is an
entry site of S. suis infection.
The capsular polysaccharide (CPS), which determines
the serotype, appears to play an essential role during the
interaction with the URT epithelium [8]. Suilysin (Sly), a
hemolytic pore-forming toxin, may also play a role facil-
itating translocation across the mucosal epithelium [9].
SS2 is responsible for most reported infections in
humans and pigs worldwide [1, 10]. However, S. suis
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serotype 9 (SS9) is the most common serotype isolated from dis-
eased pigs in Northern Europe [11] and is also prevalent in
China [12] but has never been isolated from human patients
[1, 10]. It is not known why isolates with serotypes that are high-
ly prevalent among diseased pigs, such as SS9, have never been
reported from human cases of SS infections.
In addition to serotype, the genotype contributes to virulence
of S. suis. Invasive S. suis strains are limited to certain sequence
types (ST) and multi locus sequence typing (MLST) clonal
complexes (CC) [13]. The majority of the SS2 strains isolated
from human patients belong to CC1. However, we recently
identiﬁed SS2 isolates from human patients in The Netherlands
belonging to CC20, which is unrelated to CC1, indicating that
multiple zoonotic clones are circulating worldwide [11]. In
contrast, Dutch SS9 strains isolated from diseased pigs mainly
belong to CC16, which is unrelated to both CC1 and CC20
[11, 14].
We aimed to provide experimental proof of concept that S. suis
is capable of translocation in the GIT, in the absence of any in-
vasive procedures. We then studied strain- and host-speciﬁc
factors that may modulate S. suis infectivity at the intestinal mu-
cosal surface, potentially providing clues to the zoonotic potential
of SS2.
METHODS
Animal Studies
The Danish Animal Experiments Inspectorate reviewed and ap-
proved the animal study protocol (2012-15-2934-00289). Twen-
ty speciﬁc pathogen free male piglets weaned at 5 weeks of age,
were transferred to the ABSL3 facilities at National Veterinary
Institute (DK), 2 weeks before challenge at 7 weeks of age. All
animals were SS2 free as determined by culture and real-time
polymerase chain reaction (PCR) of tonsil swabs taken upon ar-
rival. During the experimental period, 4 control and 16 inter-
vention piglets were housed in 2 separate animal boxes each,
with double HEPA ﬁltered air. The pigs were fed with a con-
trolled feed (9033, Altromin, Germany) twice daily. The day
of the experiment, piglets were transported for 1 hour over a
winding road immediately after feeding, to induce a mild stress
[15]. After the transport, the piglets were fed a gastric-acid resis-
tant capsule (23.3 × 8.53 mm, volume 0.95 mL) (Spruyt-Hillen,
NL) containing 1.2 × 109 CFUs/mL SS2 strain 3 (tetracycline re-
sistant) grown in exponential phase [16], or milk powder (con-
trols). Feces was collected in stoma bags. Piglets were monitored
every 2 hours for clinical symptoms; body weight and temper-
ature were measured daily. Daily blood samples were collected
for culture and white blood cell (WBC) counts and differentia-
tion [17–19]. Rectal and tonsil swab samples (Puritan, USA)
were collected daily for bacteriological examination. The ani-
mals were killed 72 hours postinoculation or at occurrence of
clinical signs, followed by necropsy. Tissue specimens from
tonsils, ileum, and mesenteric lymph nodes were collected for
examination.
Microbiology
Rectal and tonsil swabs were cultured overnight in selective
Todd-Hewitt broth (sTHB) supplemented with Streptococcus
Selective Supplement (Oxoid), tetracycline (10 μg/mL) and
0.01% crystal violet (2 mg/mL) (Sigma-Aldrich), and stored
at −80°C in 15% of glycerol.
Tissue swab samples were plated on Columbia agar plates
containing 6% horse blood (Oxoid) and tetracycline. Ten grams
of tissue were thoroughly crushed and stored in sTHB-15%
glycerol at −80°C. SS2 was identiﬁed by colony morphology,
and agglutination with speciﬁc antisera (SSI Diagnostica,
DK), as well as by PCR, as described previously (Supplementary
Table 1)[18, 19].
Histology
Tissue sections, embedded in parafﬁn, were stained with
haematoxylin–eosin for histological evaluation. For immuno-
histochemistry, tissue sections were stained for 2 hours with
rabbit monoclonal anti-SS2 antibody (SSI Diagnostica, DK),
followed by BrightVision Alkaline Phosphatase (AP)-conjugated
anti-rabbit immunoglobulin G (IgG; Immunologic) and Vector
Red (Vector Labs). Slides were counter stained with haematoxy-
lin, evaluated by light microscopy (Leica DMRE), and images
were captured using Nuance software.
Bacterial Strains and Intestinal Cell Lines
Strains studied are listed in Supplementary Table 1 [20, 21]. All
strains were grown in THB or on Columbia blood agar in pres-
ence of 5% CO2. Caco-2 cells (HTB-37, ATCC) and IPEC-J2
cells (ACC 701, DSMZ) were grown as described [22, 23]. Both
cell lines were seeded at 1 × 105 cells/cm2 and incubated up to
15–20 days.
Construction of a S. suis Serotype 9 Capsule Mutant
An unencapsulated mutant (8067cpsΔE) was constructed in the
wild-type (WT) SS9 strain 8067 containing the intact cps9E
gene (AF155805_2) by insertion of spectinomycin (spc) resis-
tance cassette (Supplementary Table 1). The resulting fragment
cps9E-spc was ampliﬁed and ligated to the thermo-sensitive
vector pSET5 carrying chloramphenicol resistance [24]. The
pSET5-cps9E-spc plasmid was then introduced into SS9 8067
by electroporation, and transformants were selected as de-
scribed [24]. The construct was veriﬁed by PCR and Southern
blotting.
Adherence and Invasion Assays Using Caco-2 and IPEC-J2
Cells
Bacteria were added to 24-well plates containing conﬂuent cells
at a multiplicity of infection (MOI) of approximately 10 bacte-
ria/cell. The MOI was calculated based on the number of cells/
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well at conﬂuent state (Caco-2 approximately 5.0 × 105, IPEC-J2
appproximately 2.2 × 105). Adhesion and invasion assays were
performed as previously described [25, 26]. The total number
of cell-associated bacteria (extracellular and intracellular) recov-
ered after 2 hours of incubation, was expressed as a percentage
of the original inoculum. The percentage of bacteria that invad-
ed the cells, was calculated by dividing the number of intracel-
lular bacteria (gentamicin/penicillin treatment survivors) by the
number of bacteria in the start inoculum. The percentage of
adherent bacteria was calculated by subtracting the percentage
intracellular bacteria from the percentage of cell-associated
bacteria. Adhesion and invasion tests were performed in dupli-
cate or triplicate as indicated, by 2 different operators working
in parallel. SS2 strain BM407 was included in each experiment
to control for inter-experiment variation. Low, medium, and
high adhesion were deﬁned as adhesion of 0%–10%, 10%–20%,
and ≥20% of starting inoculum, respectively.
Translocation Assay
Cells were cultured on 12-Transwell permeable polycarbonate
ﬁlters (3-µm pore size, Corning). The Trans Epithelial Electric
Resistant (TEER) across the monolayer was measured using an
epithelial tissue Volt-Ohmmeter (Millipore) every 3–4 days,
and the cells were used when a plateau was reached (approxi-
mately 500 Ω/cm2 Caco-2, approximately 300 Ω/cm2 IPEC-
J2). Bacteria were added to the upper chamber at MOI 50 and
coincubated with EICs for 6 hours. At each 2-hourly sampling,
medium in the lower chamber was replaced to prevent growth
of translocated bacteria. Samples of the upper and lower cham-
ber were taken every 2 hours and plated. We calculated the per-
centage bacterial translocation by dividing the CFUs number in
the lower chamber by the CFUs number in the upper chamber.
Data are given as mean ± SEM of at least 3 independent exper-
iments, performed in triplicates by 2 different operators. SS2
BM407 was included in each experiment. Low, medium, and
high translocation were deﬁned as 0%–0.2%, 0.2%–1.0%, and
≥1.0% of starting inoculum, respectively.
Confocal Immuno-ﬂuorescence and Transmission Electron
(TEM) Microscopy
Differentiated cells were grown on sterile glass slides pretreated
with Poly-L-lysine (Sigma-Aldrich) and infected with S. suis at
MOI 50 for 4 hours. Mouse-anti-occludin antibody (Jackson
ImmunoResearch) and rabbit anti-CPS-SS2 antibody were
incubated at room temperature (RT) for 2 hours followed by
anti-Mouse-Alexa 488 or anti-Rabbit-Cy3 (Jackson Immuno-
Research) to visualize occludin and bacteria, respectively. Nuclei
were stained using DAPI. The slides were analyzed with laser
scanning confocal microscopy (Leica TCS SP8X).
For TEM, Caco-2 cells were cultured in PET transwells and
infected with SS2 with MOI 100 for 4 hours. The MOI was en-
hanced to increase the number of events for TEM analysis. TEM
images were produced as described elsewhere [27] using FEI
Tecnai T12 microscope.
Statistical Analysis
Data were analyzed using GraphPad Prism version 6.0 (Graph-
Pad Software, USA). Data were expressed as means with stan-
dard errors (SEM). Adhesion, invasion, translocation, and
TEER values were compared by 1-way analysis of variance
(ANOVA) followed by a multiple pair-wise comparison of sam-
ple means of ranked data. Kruskal–Wallis nonparametric test
was used to determine the signiﬁcance of the differences in
adhesion, invasion, and translocation between S. suis strains
of different serotypes and genotypes.
RESULTS
S. suis Translocates the Porcine Intestinal Mucosa in Vivo
Two out of 16 orally challenged piglets showed signs and symp-
toms of systemic infection (Supplementary Table 2). Piglet 11
developed arthritis, and SS2 was cultured from its joints at 48
hours postinoculation (Supplementary Table 2). In addition,
SS2 DNA was detected in blood and cerebellum by SS2 speciﬁc
PCR (Supplementary Table 3). Piglet 10 developed signs of sep-
sis within 12 hours postinoculation, and a severe peri-esopha-
geal inﬂammation in the anterior neck region was found during
post-mortem analysis. SS2 was cultured from blood and multi-
ple organs (Supplementary Table 2). The capsule was found in
the laryngeal mucosa during post-mortem analysis of piglet 7
suggesting that the capsule had not reached the stomach. This
piglet was excluded from further analysis. Two piglets (6 and 8)
showed mild nonspeciﬁc symptoms (Supplementary Table 3).
One piglet in the control group had fever detected at planned
necropsy 72 hours postinoculation. The remaining piglets did
not exhibit any clinical signs of SS infection until euthanasia,
and infection related gross pathological changes or changes at
the inoculation site were not observed at post-mortem analysis.
However, culture of joint ﬂuid of piglet 12 yielded SS2.
In 6 out of 15 challenged piglets, intestinal mesenteric lymph
nodes (IMLNs) were positive in PCR (Supplementary Table 3).
For all positive IMLNs, with the exception of IMLNs from piglet
14, the presence of viable SS2 was conﬁrmed by culture. Intes-
tinal scrapings were positive by PCR in 2 of the 6 piglets with
positive IMLNs and in 1 additional piglet. All tonsils swabs were
negative at t = 0 before challenge, whereas 7 piglets (4 of which
with positive IMLNs), had SS2 positive tonsil swabs after 48
hours (Supplementary Table 3). In none of the control piglets
and the remaining 6 challenged piglets, SS2 was detected in
any of the sampled sites and organs by PCR.
Histological analysis of the intestinal mucosa did not reveal
pathological changes in the epithelium. In addition, we did not
observe inﬂux of granulocytes in the lamina propria of the intes-
tinal mucosa or into the sinuses of the IMLNs (data not shown).
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Immunohistochemistry of jejunum and colon sections of piglet
11 indicated the presence of SS2 in the apical part of the mucosa
(Figure 1). SS2 was detected by immunohistochemistry in tonsil
sections of 6 infected piglets, all of which were positive in PCR.
Adhesion to Human and Porcine IEC is Associated With
Serotype and Genotype
We included 48 S. suis strains isolated from human patients
with meningitis, diseased and carrier pigs, and originating
from The Netherlands and Vietnam in a period from 1982 to
2008 (Supplementary Table 1).
Serotype was signiﬁcantly associated with adhesion to host
cells of different origin (Figure 2A and 2B). SS2 strains showed
signiﬁcantly more adhesion to human Caco-2 cells compared
with SS1 and SS9 strains (Figure 2A). In contrast, SS9 strains
adhered more efﬁciently to the porcine IPEC-J2 cells compared
with SS2 and SS1 strains (Figure 2A). In a genotype com-
parison, strains of CC20 and CC1 showed signiﬁcantly more
adhesion to Caco-2 cells than the strains of CC13 and CC16
(Figure 2B). In contrast, strains of CC16 adhered signiﬁcantly
better to IPEC-J2 cells than strains representing all the other ge-
notypes (Figure 2B). Thus, we observed differential adhesion of
S. suis to IECs of human or porcine origin, which correlated
with the serotype of the strains.
All strains tested showed poor invasion of Caco-2 cells, with
the exception of a subset of ﬁve SS1 strains of CC13 (Figure 2C).
Invasion of IPEC-J2 cells was virtually absent, in particular for
SS1 and SS9 strains (Figure 2D).
We observed a signiﬁcant increase in adhesion to Caco-2 cells
for both unencapsulated mutant strains compared to their
parent strains (Supplementary Table 1; Figure 3A). The unen-
capsulated SS9 showed higher adhesion capacity to porcine
IPEC-J2 compared to its parent, whereas the unencapsulated
SS2 had a similar adhesion capacity compared to its parent.
Both unencapsulated mutants were able to invade both hu-
man and porcine IECs more efﬁciently than their parent strains.
However, the unencapsulated SS2 strain appeared to have a
higher invasion capacity compared to the SS9 mutant strain
for both cell lines (P < .05; Figure 3B).
Translocation Capacity Across Human Polarized IEC is
Associated With Genotype
We did not observe signiﬁcant differences in translocation ca-
pacity between strains of different serotypes (Figure 4A). In
contrast, when comparing translocation across CCs, signiﬁ-
cantly higher mean translocation percentages for CC1 strains
(0.95%) compared to CC20 strains (0.30%) and CC16 strains
(0.31%) were observed (P < .05). Although the small number
Figure 1. S. suis serotype 2 (SS2) in intestinal mucosa tissue derived from SS2 free piglets after oral SS2 challenge. Multi-spectral imaging of immu-
nohistochemistry staining of intestinal tissue of piglet 1 (not infected, jejunum) and piglet 11 ( jejunum and colon). Sections were stained with hematoxylin
1×. SS2 was detected using rabbit monoclonal anti-SS2 antibody. Slides were evaluated by light microscopy using 2.5×, 20× and 63× immersion oil ob-
jectives in digital bright ﬁeld image and digital ﬂuorescence (Nuance software).
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Figure 2. S. suis strains associated with different ability to adhere to and invade the human and porcine IEC. A and B, Multiple comparisons of S. suis strains with different serotypes (SS) (A) and genotypes
(CC) (B) for their adhesion to human (Caco-2) and porcine (IPEC-J2) EIC. C and D, Multiple comparisons of S. suis strains with different serotypes (SS) (C) and genotypes (CC) (D) for their invasion capacity to Caco-
2 and IPEC-J2 cells. Serotypes analyzed: SS1 ▪, SS2 • and SS9 ▴. MLST Clonal Complex (CC) CC1, CC20, CC13 and CC16 strains are indicated in red, grey, green, and blue respectively. Genotypes analyzed: CC1
•, CC20 ▪, CC13 ▴, and CC16 ▾. SS2, SS9 and SS1 strains are indicated in red, blue and green, respectively. Lines denote the median percentage of adhesion for each group of strains. *P < .05; **P < .01;
***P < .001 (Kruskal–Wallis test).
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of CC13 strains precluded statistical analysis, results suggest a
low translocation capacity. Strains of CC20 did not translocate
efﬁciently across the epithelial monolayer, with the exception of
three strains (Figure 4B).
For a subset of strains, which demonstrated high or low trans-
location capacity across Caco-2 cells, we analyzed the transloca-
tion across IPEC-J2 cells. We observed similar translocation
capacity across both IECs (Supplementary Figure 1A).
Cell monolayers were still viable after 6 hours of bacterial co-
culture as determined with propidium iodide [28] (data not
shown). We measured the change in TEER induced by strains
of each serotype and genotype under study, which showed high
and low translocation (HT and LT, respectively) (Supplementa-
ry Figure 1B). TEER values decreased by 20% after 2 hours of
infection but returned to baseline levels after 6 hours for HT
strains, indicating that monolayer integrity was maintained
for the duration of the 6-hour assay. For LT strains, an increase
in TEER of approximately 30% from baseline after 6 hours of
infection was observed.
The 2 unencapsulated mutant strains showed 2-fold in-
creased translocation capacity compared to the capsulated
WTs over all time points tested (data for 6-hour infection
shown in Figure 4C).
SS2 strain P1/7 strain translocated across Caco-2 cells slightly
better than its isogenic P1/7Δsly suilysin mutant [20] after 6
hours of co-incubation. In contrast, the P1/7Δsly mutant strain
exhibited a signiﬁcantly reduced translocation across IPEC-J2
cells after 6 hours of coincubation (Figure 4D).
S. suis can Damage the Tight Junctions (TJ) of IEC Monolayers
SS2 strain BM407 did not cause macroscopic damage to the
monolayer after 2 hours of coincubation, but we observed dis-
ruption of cell borders with reduced staining of TJ (Figure 5).
Bacteria clustered at the junctions between Caco-2 cells. Confo-
cal microscopy of Caco-2 and IPEC-J2 cells, incubated with
strains with high, medium and low adhesion/translocation ca-
pacity (Figure 5), showed a strong correlation between TJ dam-
age and the adhesion/translocation capacity of the strains.
Figure 3. The polysaccharide capsule hampers S. suis adhesion to and invasion of human and porcine IEC. A, Adhesion and (B) invasion of Caco-2 and
IPEC-J2 cells displayed by the wild type (WT) strains SS2 strain 10 and SS9 strain 8067 and their isogenic unencapsulated mutants 10cpsΔEF and
8067ΔcpsΔE respectively. Data are given as means ± standard error of the mean (SEM) of at least 2 separate experiments performed in triplicate and
analyzed by 1-way analysis of variance (ANOVA). *P < .05; **P < .001.
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Three-dimensional confocal imaging showed clusters of ﬂuores-
cent bacteria, some of which co-localized with TJ (Figure 6A). Z-
stack images from the apical (0 µm) to the basolateral (180 µm)
side conﬁrmed that SS2 BM407 bacteria could be found in close
contact with the TJ and at the basolateral side of the monolayer
(Figure 6A). Caco-2 cells infected with SS2 strain BM407 were
characterized by a deteriorated microvilli brush border when
compared to uninfected Caco-2 cells (Figure 6B). Adherent bac-
teria were observed in close contact with the apical microvilli of
the intestinal cells. Translocating bacteria were found in close
vicinity of TJ as well as in intracellular vacuole (Figure 6B).
DISCUSSION
We have provided experimental evidence that the GIT repre-
sents an entry site of S. suis infection. Two out of 15 evaluable
piglets developed clinical symptoms after oral challenge with
SS2. Our results are in accordance with a previous study on S.
suis intestinal translocation, in which S. suis were recovered
from the organs of 3 out of 11 piglets infected through a catheter
placed surgically in the duodenum [7]. The relatively small
number of diseased animals after oral infection may be ex-
plained by a slow translocation process of S. suis through the
intestinal mucosa, which is dependent on multiple factors, in-
cluding host intestinal homeostasis, immune clearance mecha-
nisms, and bacterial growth rate [22, 29]. A longer observation
period may have resulted in more piglets with clinical symp-
toms of infection. One line of defense in intestinal homeostasis
includes the IMLNs [29, 30]. Viable S. suis were detected in the
IMLNs of 6 infected piglets (40%) indicating bacterial intestinal
translocation (Supplementary Table 3). Listeria monocytogenes
was shown to migrate extracellularly to IMLNs or to be carried
inside migratory phagocytes such as dendritic cells (DCs) [30].
S. suis was also shown to bind and survive inside DCs for
Figure 4. Genetic background of S. suis determines the translocation across human IEC. A, Multiple comparisons of S. suis translocation across dif-
ferentiated Caco-2 monolayers after 6 h of co-incubation, analyzed by S. suis serotype (SS): SS1 ▪, SS2 • and SS9 ▴. MLST Clonal Complex (CC) CC1, CC20,
CC13 and CC16 strains are indicated in red, grey, green, and blue respectively. B, Multiple comparisons of S. suis translocation across differentiated Caco-2
monolayers after 6 h of co-incubation, analyzed by S. suis genotype: MLST clonal complex (CC) CC1 •, CC20 ▪, CC13 ▴, and CC16 ▾. SS2, SS9 and SS1
strains are indicated in red, blue, and green, respectively. Lines denote the median percentage of translocation for each group of strains, analyzed by
Kruskal–Wallis test. C, Comparison of bacterial translocation efﬁciency of unencapsulated (10cpsΔEF and 8067ΔcpsΔE) mutant strains and their wild-
type parent strains across differentiated human (Caco-2) and porcine (IPEC-J2) IEC. D, Comparison of bacterial translocation efﬁciency of a suilysin mutant
(P1/7Δsly) and its wild-type parent strain across differentiated human (Caco-2) and porcine (IPEC-J2) IEC. Data are given as means ± standard error of the
mean (SEM) of at least 2 independent experiments, each performed in triplicate and analyzed by 1-way analysis of variance (ANOVA). *P < .05; **P < .01;
***P < .001.
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24 hours [31]. Bacterial spread via the lymphatic system may
explain how not only IMLNs but also tonsils became SS2 pos-
itive. However, we cannot rule out that tonsils were colonized
shortly after inoculation, for example, due to gastro-esophageal
reﬂux after the ingested capsule had dissolved.
In order to gain insight into how S. suis interacts with intes-
tinal epithelial cells, we established an in vitro model using
human (Caco-2) and porcine (IPEC-J2) intestinal epithelial
cells. SS2 strains, including strain 3 used for oral challenge of
piglets, adhered signiﬁcantly better to human Caco-2 cells,
Figure 5. S. suis strains with high translocation capacity induce re-arrangement of Tight Junction (TJ) of Caco-2 and IPEC-J2 cells. Confocal imaging of
A, Caco-2 and B, IPEC-J2 intestinal epithelial cells stained for TJ protein occludin (green) in the absence (control) and in the presence of S. suis strains with
low (+) medium (++), high (+++),adhesion (A) and translocation (T) ability, after 4 h of co-incubation (see “Materials and Methods” section for deﬁnitions of
low, medium, and high). Bacteria (red) were stained with rabbit monoclonal antisera raised against capsular polysaccharides of serotype 2 and were coun-
terstained with Alexa Fluor 488–conjugated anti-rabbit antibodies. Co-localization of bacteria and TJ (yellow). Bar 10 µm.
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Figure 6. S. suis co-localizes with cellular junctions and translocates from the apical to the basolateral side of polarized IEC. A, 3D confocal images of
Caco-2 and IPEC-J2 cell layers stained for the TJ protein occludin (green) in the absence (control) and in the presence of S. suis 2 BM407 (red) after 4 h
incubation. The nuclei of intestinal cells are stained with DAPI (blue). Lower and side strips are relative to x and y sections through the monolayer where Z-
stack images are made from the apical (0 µm) to the basolateral (180 µm) side. Bacteria stained in light pink indicate co-localization with occludin (black
arrow). B, TEM of differentiated Caco-2 cells ﬁxed at 4 h after infection with S. suis serotype 2 strain BM407. SS2 strain BM407 adheres to the apical
microvilli after apical infection (yellow arrows). Translocating bacteria (red arrows) are found in close vicinity to tight junctions and within a vacuole (*).
Images were made at magniﬁcations of 2500×, 5000× and 10 000×. Bar: 10, 5 or 2 µm as indicated.
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whereas SS9 strains showed higher adhesion to porcine IPEC-J2
cells. Adhesion increased signiﬁcantly in the absence of the
polysaccharide capsule of serotypes 2 and 9. The S. suis capsule
thus appears to inﬂuence bacterial adhesion through its primary
structure as well as by partially masking of bacterial adhesins,
reducing the binding of bacteria to the host cells. Differences
in primary structure of capsule, such as differences in sialic
acid content, may contribute to the differences in cell-
microbe-interaction during adhesion between SS2 and SS9
strains. Several adhesins of S. suis have been described [32], in-
cluding the Streptococcal Adhesin P (SadP) [33], which was
shown to bind to galactosyl-(α1,4)-galactose-containing glyco-
lipids present in the cell membranes of human and porcine IEC,
such as Caco-2 and IPEC-J2 cells [34, 35]. Analysis of available
protein sequences of SadP, reveals substantial variation at
amino acid level across different serotypes and genotypes
(data not shown). Differences in adhesin structure and/or in re-
ceptor afﬁnity may provide a clue to the observed differences in
adhesion to IEC between strains and hosts.
Several enteric pathogens can migrate across a polarized ep-
ithelium using a transcellular and/or paracellular route [36, 37].
In addition, other streptococci were shown to translocate across
Caco-2 cells using a paracellular route [27, 38, 39]. Thus, para-
cellular passage of epithelial cells is a common mechanism ap-
plied by bacterial pathogens to penetrate the intestinal mucosa.
For S. suis, the production of suilysin is not essential, whereas
the capsule appears to interfere with this passage. Expression of
virulence features, including capsule and suilysin, are regulated
by environmental pressures such as nutrient availability [25].
Changes in these environmental conditions during passage or
colonization of the human or porcine GIT may induce changes
in virulence factors expression such as capsule, which favor sub-
sequent bacterial translocation.
SS2 is the most common cause of zoonotic S. suis infection
[1, 40]. Human carriage of SS2 is probably very rare [3] and
human-to-human transmission has never been documented.
It is striking how the interaction of S. suis of different serotypes
with different host cells correlates with zoonotic potential; inva-
sive strains isolated from human patients (SS2; CC1, or CC20)
showed signiﬁcantly higher adhesion to Caco-2 cells of human
origin compared to a representative selection of invasive strains
isolated from pigs (predominantly SS9; CC16). In contrast,
these same strains isolated from pigs showed signiﬁcantly high-
er adhesion to IPEC-J2 cells of porcine origin.
In addition, translocation across human EICs was associated
with CC1, which is the genotype most commonly found in
human patients, even if other genotypes are more prevalent in
porcine disease, as was demonstrated in The Netherlands [11].
However, the majority of human isolates belonging to CC20
showed a low translocation capacity across Caco-2 cells. We hy-
pothesize that virulent S. suis strains, including CC20, can use
multiple mechanisms of infection and spread into the host, after
initial adhesion to host epithelial cells. The intestinal route of
infection is less likely to occur in The Netherlands because
high-risk S. suis contaminated food, such as raw pig blood or
fermented raw pork, is rarely on the menu. Direct passage of
S. suis into the blood stream, after exposure to slaughtered
pigs in the presence of skin injuries, is the most common
route of infection and CC20 strains may be well equipped to
achieve this.
CONCLUSIONS
SS2 infection is a food-borne disease and interventions to
reduce colonization of piglets with highly virulent S. suis, in
the beneﬁt of both veterinary and human health, should include
interventions to reduce gastro-intestinal colonization.
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